Lynne D. Berry

Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

Mark G. Kris, Bruce E. Johnson, Lynne D. Berry et al. · JAMA · 2014 · 1.7K citations · Full text

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience

Lynette M. Sholl, Dara L. Aisner, Marileila Varella‐Garcia et al. · Journal of Thoracic Oncology · 2015 · 421 citations · Full text

Oncology, Somatic Variant, Oncogenic Agent +8

Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps

Bob Chen, Cherie’ R. Scurrah, Eliot T. McKinley et al. · Cell · 2021 · 313 citations · Full text

Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience

Badi El Osta, Madhusmita Behera, Sungjin Kim et al. · Journal of Thoracic Oncology · 2019 · 235 citations · Full text

Medicine, Pathology, Cancer Genomics +5

Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma

Dale Han, Jonathan S. Zager, Yu Shyr et al. · Journal of Clinical Oncology · 2013 · 221 citations